Fein A M, Duvivier R
Pulmonary and Critical Care Medicine Division, Winthrop-University Hospital, Mineola, New York.
Clin Chest Med. 1992 Dec;13(4):709-22.
Sepsis remains an uncommon, but potentially devastating problem in the previously healthy pregnant patient. Although septic sequelae, including organ failure and shock, are unusual, they are likely to lead to morbidity and mortality as high, or higher, than in the general population. At the present time, hemodynamic support, surgery, and antimicrobial therapy aimed at reducing polymicrobial aerobic and anaerobic infection remain the gold standard of therapy. New antimediator and anti-inflammatory therapies offer promise of improved survival in the general and obstetric population with severe sepsis.
脓毒症在既往健康的孕妇中仍然是一个不常见但可能具有毁灭性的问题。尽管包括器官衰竭和休克在内的脓毒症后遗症并不常见,但它们导致的发病率和死亡率可能与普通人群一样高,甚至更高。目前,旨在减少需氧菌和厌氧菌混合感染的血流动力学支持、手术及抗菌治疗仍然是治疗的金标准。新的抗介质和抗炎治疗为改善严重脓毒症普通人群及产科人群的生存率带来了希望。